Financial Architects, Inc Age X Therapeutics, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.25 - $1.82 $500 - $728	-400 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.0 - $4.85 $1,200 - $1,939	400 New	400 $2,000
Q1 2019 May 03, 2019	SELL	$3.0 - $4.85 $1,200 - $1,939	-400 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$2.49 - $5.5 $996 - $2,200	400 New	400 $1,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.